Physician profile
Lori A Foster
NPI 1871584102
$9,820.42
in general payments reported to CMS, 2019-2025
57 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what 95% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,170 · 2022: $2,818 · 2023: $1,879 · 2024: $1,832 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,831.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,064.82 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $952.52 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $814.28 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $724.70 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $636.53 | 2021-2025 | |
| Abbott Laboratories | $518.65 | 2021-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $509.06 | 2022-2025 | Rexulti, Abilify Maintena |
| Pfizer INC. | $436.74 | 2021-2025 | |
| Tandem Diabetes Care, INC. | $408.61 | 2021-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $371.48 | 2021-2025 | Otezla, Repatha, Prolia |
| Medtronic, INC. | $241.24 | 2022-2025 | Minimed 780g |
| Amarin Pharma, INC. | $220.23 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.30 | 2021-2024 | Jardiance |
| Xeris Pharmaceuticals, INC. | $184.25 | 2021-2024 | Gvoke Hypopen |
| Antares Pharma, INC. | $178.85 | 2021-2022 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.